Biomarkers of Aging: What's Worth Tracking

The promise of an “aging biomarker” is seductive: a single number that tells you whether you are aging faster or slower than the calendar. The reality is messier. Some markers are well validated and clinically actionable. Others are interesting research tools that get marketed as personal dashboards long before the science supports individual decisions. Sorting the two is the whole game.

The distinction that matters

There is a useful split between markers that predict outcomes at a population level and markers that should change what you do as an individual. A test can be a strong epidemiological predictor and still be a poor basis for personal action — because the year-to-year noise swamps the signal, or because no intervention has been shown to move both the marker and the outcome.

The honest limit: very few “aging clocks” have been shown to improve health when you act on them. Predicting risk is not the same as having a lever you can pull.

Markers with a strong, boring track record

These are unglamorous but genuinely decision-relevant:

• Blood pressure — one of the most reliable predictors of healthy lifespan, and modifiable.
• Fasting glucose and HbA1c — metabolic trajectory, well validated, responsive to behavior.
• ApoB or LDL particle measures — cardiovascular risk with clear interventions.
• Resting and recovery heart rate, VO2 capacity — fitness markers that track hard outcomes.
• Grip strength — a surprisingly durable proxy for whole-body resilience in older adults.

Markers that are promising but oversold

• Epigenetic clocks (DNA methylation age) — fascinating, improving, but with meaningful test-retest variability and unproven individual actionability.
• Inflammatory panels (hs-CRP, IL-6) — informative in aggregate, noisy and nonspecific individually.
• Telomere length — historically hyped, weak as a personal metric.

How to think about tracking

A few principles keep this useful rather than anxiety-inducing:

1. Favor markers tied to interventions you would actually act on.
2. Trust trends over single readings; biological noise is large.
3. Be wary of any panel that produces a tidy “biological age” number without disclosing its uncertainty.

The most defensible personal dashboard is unexciting: standard metabolic and cardiovascular labs, a fitness measure, and a strength measure, tracked over time.

The takeaway

The best aging biomarkers right now are mostly the ones your doctor already orders, plus a couple of fitness metrics. The futuristic clocks are scientifically real and worth watching, but the data do not yet support reorganizing your life around your methylation age. Track what you can change, watch trends not points, and treat any single “age in a number” with calm skepticism.

This is sample content created during site scaffolding. Replace with reviewed, fully-cited editorial before launch.